|
1
|
Human skin Langerhans cells are targets of dengue virus infection.
|
Nat Med
|
2000
|
5.74
|
|
2
|
Haiti: absence of dengue hemorrhagic fever despite hyperendemic dengue virus transmission.
|
Am J Trop Med Hyg
|
2001
|
2.35
|
|
3
|
Simplified plaque reduction neutralization assay for dengue viruses by semimicro methods in BHK-21 cells: comparison of the BHK suspension test with standard plaque reduction neutralization.
|
J Clin Microbiol
|
1985
|
2.31
|
|
4
|
Human dendritic cells as targets of dengue virus infection.
|
J Investig Dermatol Symp Proc
|
2001
|
1.96
|
|
5
|
Absence of dengue 2 infection enhancement in human sera containing Japanese encephalitis antibodies.
|
Am J Trop Med Hyg
|
1984
|
1.04
|
|
6
|
Detection of dengue viral RNA using a nucleic acid sequence-based amplification assay.
|
J Clin Microbiol
|
2001
|
1.02
|
|
7
|
Immunogenicity of live attenuated SA14-14-2 Japanese encephalitis vaccine--a comparison of 1- and 3-month immunization schedules.
|
J Infect Dis
|
1998
|
0.91
|
|
8
|
Selection of attenuated dengue 4 viruses by serial passage in primary kidney cells. III. Reversion to virulence by passage of cloned virus in fetal rhesus lung cells.
|
Am J Trop Med Hyg
|
1984
|
0.79
|
|
9
|
Selection of attenuated dengue 4 viruses by serial passage in primary kidney cells. IV. Characterization of a vaccine candidate in fetal rhesus lung cells.
|
Am J Trop Med Hyg
|
1984
|
0.77
|
|
10
|
Selection of attenuated dengue 4 viruses by serial passage in primary kidney cells. II. Attributes of virus cloned at different dog kidney passage levels.
|
Am J Trop Med Hyg
|
1984
|
0.75
|